Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis

BACKGROUND: Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for the treatment of diabetic wound healing. The present study aimed to investigate the effect of exosomes derived from MSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yiqiang, Tao, Ranyang, Chen, Lang, Xiong, Yuan, Xue, Hang, Hu, Liangcong, Yan, Chenchen, Xie, Xudong, Lin, Ze, Panayi, Adriana C., Mi, Bobin, Liu, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139165/
https://www.ncbi.nlm.nih.gov/pubmed/34020670
http://dx.doi.org/10.1186/s12951-021-00894-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139165/
https://www.ncbi.nlm.nih.gov/pubmed/34020670
http://dx.doi.org/10.1186/s12951-021-00894-5

Ejemplares similares